CL219: SuperIntelligence And The Ethics Of AI – Interview with Greg Keiser
Greg Kieser is the founder of Supersystemic.ly, a Brooklyn-based think-tank and angel investment firm dedicated to increasing humanity’s readiness for the emergence of superintelligent entities through the study and spread of “supersystemic” perspectives and innovations. Kieser previously oversaw a portfolio of technology initiatives at an NYC-based poverty-fighting foundation. His new book, Dear Machine: A Letter […]
CL218: Strategies For Innovating The Customer Experience – Interview with Christian Terwiesch
Christian Terwiesch is a professor in Wharton’s Operations and Information Management department and co-director of Penn’s Mack Institute for Innovation Management. He also holds a faculty appointment in Penn’s Perelman School of Medicine. Christian launched the first Massive Open Online Course (MOOC) in business on the Coursera platform and by now, well over half a […]
CL217: Hacking Darwin: Genetic Engineering And The Future Of Humanity – Interview with Jamie Metzl
Jamie Metzl is a technology futurist, geopolitical expert, novelist, entrepreneur, media commentator, and Senior Fellow of the Atlantic Council. In February 2019, he was appointed to the World Health Organization expert advisory committee on developing global standards for the governance and oversight of human genome editing. Jamie previously served in the U.S. National Security Council, […]
CL216: The Artist Entrepreneur – Interview with Catherine Orer
Catherine Orer is an award-winning Business & PR Strategist and founder of The Artist Entrepreneur, where she counsels professional visual artists and creative entrepreneurs who want to build sustainable businesses and careers. After working as a PR professional for multinational corporations, and then for art galleries in Paris and North America, she decided to create […]
CL215: Loonshots And The Problem With Disruptive Innovation – Interview with Safi Bahcall
Safi Bahcall is the author of Loonshots. After studying physics at Harvard and Stanford, he founded a biotech company specializing in cancer drugs, led its IPO, and served as its CEO for 13 years. He was named the Ernst & Young Entrepreneur of the Year in 2008 and in 2011, he worked with President Obama’s […]